Literature DB >> 36006425

[Treatment of keloids at the ear].

Fabienne Oettgen1, Frank Haubner2.   

Abstract

Keloids belong to the group of fibroproliferative diseases and clinically often present with functional and cosmetic impairment of the patient, as well as with pruritus and pain. The pathogenesis of keloids has not been definitively clarified and treatment is often protracted and less than satisfactory. A variety of therapeutic options are available for treatment of keloids; however, the evidence base is small due to studies with low case numbers. Use of multimodal treatment concepts seems to be promising and has shown good results, especially in the treatment of auricular keloids.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Combined modality therapy; External Ear; Granulation tissue; Hypertrophic scars; Wound closure techniques

Mesh:

Year:  2022        PMID: 36006425     DOI: 10.1007/s00105-022-05043-z

Source DB:  PubMed          Journal:  Dermatologie (Heidelb)        ISSN: 2731-7005


  33 in total

Review 1.  [The treatment of keloids].

Authors:  I Hackert; R Aschoff; G Sebastian
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

Review 2.  International clinical recommendations on scar management.

Authors:  Thomas A Mustoe; Rodney D Cooter; Michael H Gold; F D Richard Hobbs; Albert-Adrien Ramelet; Peter G Shakespeare; Maurizio Stella; Luc Téot; Fiona M Wood; Ulrich E Ziegler
Journal:  Plast Reconstr Surg       Date:  2002-08       Impact factor: 4.730

Review 3.  Keratinocyte-fibroblast interactions in wound healing.

Authors:  Sabine Werner; Thomas Krieg; Hans Smola
Journal:  J Invest Dermatol       Date:  2007-05       Impact factor: 8.551

Review 4.  Complications of surgery of the external ear.

Authors:  D W Furnas
Journal:  Clin Plast Surg       Date:  1990-04       Impact factor: 2.017

5.  Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.

Authors:  Masao Fujiwara; Yasuteru Muragaki; Akira Ooshima
Journal:  Arch Dermatol Res       Date:  2005-10-26       Impact factor: 3.017

6.  Recombinant human endostatin reduces hypertrophic scar formation in rabbit ear model through down-regulation of VEGF and TIMP-1.

Authors:  Peng Wang; Li-Zhu Jiang; Bin Xue
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 7.  Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.

Authors:  E E Tredget; B Nedelec; P G Scott; A Ghahary
Journal:  Surg Clin North Am       Date:  1997-06       Impact factor: 2.741

8.  Keloids in the African.

Authors:  J O Oluwasanmi
Journal:  Clin Plast Surg       Date:  1974-01       Impact factor: 2.017

9.  Biologic basis for the treatment of keloids and hypertrophic scars.

Authors:  E E Peacock; J W Madden; W C Trier
Journal:  South Med J       Date:  1970-07       Impact factor: 0.954

Review 10.  Transforming growth factor beta (TGFbeta) and keloid disease.

Authors:  Jagajeevan Jagadeesan; Ardeshir Bayat
Journal:  Int J Surg       Date:  2006-06-15       Impact factor: 6.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.